{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T18:01:45Z","timestamp":1784656905652,"version":"3.55.0"},"reference-count":39,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T00:00:00Z","timestamp":1769212800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"\u201cIuliu Ha\u021bieganu\u201d University of Medicine and Pharmacy Cluj-Napoca, Romania, Doctoral Research Program","award":["PCD 771\/8\/11.01.2023"],"award-info":[{"award-number":["PCD 771\/8\/11.01.2023"]}]},{"name":"European Union\u2014NextGenerationEU","award":["760072\/23.05.2023"],"award-info":[{"award-number":["760072\/23.05.2023"]}]},{"name":"European Union\u2014NextGenerationEU","award":["CF 16\/15.11.2022"],"award-info":[{"award-number":["CF 16\/15.11.2022"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: Pancreatic ductal adenocarcinoma (PDAC) is among the most aggressive, heterogeneous, and lethal human malignancies, underscoring the urgent need for novel, targeted therapeutic strategies for neo(adjuvant) individualized treatment. The epidermal growth factor receptor family (ErbB) is directly involved in abnormal cell proliferation and tumor growth. The overexpression and amplification of HER2 and HER3 have emerged as key molecular events in pancreatic ductal adenocarcinoma. The aim of this study was to evaluate these membrane receptors\u2019 overexpression in relation to pTNM staging, perineural and lymphovascular invasion, and tumor volume in order to obtain the immunohistochemical profile and enhance the development of a targeted and personalized therapy. Materials and Methods: An observational analytical cohort study included patients with histopathologically na\u00efve, confirmed PDAC who underwent cephalic pancreatoduodenectomy at a national high-volume referral center between 2017 and 2022. Archived surgical specimens were retrieved and examined using a tissue microarray technique in two separate pathology departments by two independent pathologists. Results: HER2 positivity was found in 25 cases, of which 84% had lymphatic invasion, 50% had vascular invasion, and 84% had perineural invasion. Patients with HER3 positivity had lymphatic invasion (82.5%), perineural invasion (79.4%), and vascular invasion (38.1%). Combined HER2 and HER3 positivity was present in 19 cases, and these patients had 84.2% perineural invasion. Conclusions: HER2 and HER3 overexpression often coexisted with pathological features, such as perineural invasion, in cases of combined HER2 and HER3 positivity. These findings support the involvement of the ErbB receptor family in pancreatic carcinogenesis and suggest their potential as targets for future (neo)adjuvant therapeutic strategies.<\/jats:p>","DOI":"10.3390\/medicina62020251","type":"journal-article","created":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T10:24:36Z","timestamp":1769423076000},"page":"251","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Pattern of HER2 and HER3 Overexpression in Patients with Pancreatic Ductal Adenocarcinoma"],"prefix":"10.3390","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1239-4337","authenticated-orcid":false,"given":"Ioan C\u0103t\u0103lin","family":"Bodea","sequence":"first","affiliation":[{"name":"Department of Surgery, \u201cIuliu Ha\u021bieganu\u201d University of Medicine and Pharmacy, 400162 Cluj-Napoca, Romania"},{"name":"Department of Surgery, \u201cOctavian Fodor\u201d Regional Institute of Gastroenterology and Hepatology, 400162 Cluj-Napoca, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0126-6428","authenticated-orcid":false,"given":"Andra","family":"Ciocan","sequence":"additional","affiliation":[{"name":"Department of Surgery, \u201cIuliu Ha\u021bieganu\u201d University of Medicine and Pharmacy, 400162 Cluj-Napoca, Romania"},{"name":"Department of Surgery, \u201cOctavian Fodor\u201d Regional Institute of Gastroenterology and Hepatology, 400162 Cluj-Napoca, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9618-9359","authenticated-orcid":false,"given":"Florin Vasile","family":"Zaharie","sequence":"additional","affiliation":[{"name":"Department of Surgery, \u201cIuliu Ha\u021bieganu\u201d University of Medicine and Pharmacy, 400162 Cluj-Napoca, Romania"},{"name":"Department of Surgery, \u201cOctavian Fodor\u201d Regional Institute of Gastroenterology and Hepatology, 400162 Cluj-Napoca, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raluca","family":"Bodea","sequence":"additional","affiliation":[{"name":"Department of Surgery, \u201cOctavian Fodor\u201d Regional Institute of Gastroenterology and Hepatology, 400162 Cluj-Napoca, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0218tefan","family":"Ursu","sequence":"additional","affiliation":[{"name":"Department of Surgery, \u201cIuliu Ha\u021bieganu\u201d University of Medicine and Pharmacy, 400162 Cluj-Napoca, Romania"},{"name":"Department of Surgery, \u201cOctavian Fodor\u201d Regional Institute of Gastroenterology and Hepatology, 400162 Cluj-Napoca, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0252-8258","authenticated-orcid":false,"given":"R\u0103zvan Alexandru","family":"Ciocan","sequence":"additional","affiliation":[{"name":"Department of Surgery-Practical Abilities, \u201cIuliu Ha\u021bieganu\u201d University of Medicine and Pharmacy, 400337 Cluj-Napoca, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9963-561X","authenticated-orcid":false,"given":"R\u0103zvan George","family":"Bogdan","sequence":"additional","affiliation":[{"name":"Plastic Surgery Department, \u201cVictor Babes\u201d University of Medicine and Pharmacy, 300041 Timisoara, Romania"},{"name":"County Clinical Emergency Hospital Pius Branzeu, 300723 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alin","family":"Fetti","sequence":"additional","affiliation":[{"name":"Department of Surgery, \u201cIuliu Ha\u021bieganu\u201d University of Medicine and Pharmacy, 400162 Cluj-Napoca, Romania"},{"name":"Department of Surgery, \u201cOctavian Fodor\u201d Regional Institute of Gastroenterology and Hepatology, 400162 Cluj-Napoca, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2342-4311","authenticated-orcid":false,"given":"Sorana D.","family":"Bolboac\u0103","sequence":"additional","affiliation":[{"name":"Department of Medical Informatics and Biostatistics, \u201cIuliu Hatieganu\u201d University of Medicine and Pharmacy Cluj-Napoca, 400349 Cluj-Napoca, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filip Cristian","family":"Tocoian","sequence":"additional","affiliation":[{"name":"Department of Surgery, \u201cOctavian Fodor\u201d Regional Institute of Gastroenterology and Hepatology, 400162 Cluj-Napoca, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bobe","family":"Petrushev","sequence":"additional","affiliation":[{"name":"Department of Pathology, \u201cOctavian Fodor\u201d Regional Institute of Gastroenterology and Hepatology, 400162 Cluj-Napoca, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Maria","family":"Fit","sequence":"additional","affiliation":[{"name":"Department of Pathology, \u201cOctavian Fodor\u201d Regional Institute of Gastroenterology and Hepatology, 400162 Cluj-Napoca, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioana","family":"Rusu","sequence":"additional","affiliation":[{"name":"Department of Pathology, \u201cOctavian Fodor\u201d Regional Institute of Gastroenterology and Hepatology, 400162 Cluj-Napoca, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roxana Liana","family":"Popa","sequence":"additional","affiliation":[{"name":"Department of Pathology, \u201cOctavian Fodor\u201d Regional Institute of Gastroenterology and Hepatology, 400162 Cluj-Napoca, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5986-1233","authenticated-orcid":false,"given":"Nadim","family":"Al Hajjar","sequence":"additional","affiliation":[{"name":"Department of Surgery, \u201cIuliu Ha\u021bieganu\u201d University of Medicine and Pharmacy, 400162 Cluj-Napoca, Romania"},{"name":"Department of Surgery, \u201cOctavian Fodor\u201d Regional Institute of Gastroenterology and Hepatology, 400162 Cluj-Napoca, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,1,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s12029-025-01183-2","article-title":"Trends in the Global Incidence of Pancreatic Cancer and a Brief Review of its Histologic and Molecular Subtypes","volume":"56","author":"Premila","year":"2025","journal-title":"J. Gastrointest. Cancer"},{"key":"ref_2","first-page":"74","article-title":"Pancreatic Cancer: Early Detection and Novel Therapies","volume":"3","author":"Murthy","year":"2025","journal-title":"J. Transl. Gastroenterol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.bpg.2005.10.001","article-title":"Epidemiology and risk factors for pancreatic cancer","volume":"20","author":"Lowenfels","year":"2006","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1159\/000123838","article-title":"Pancreatic carcinogenesis","volume":"8","author":"Koorstra","year":"2008","journal-title":"Pancreatology"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.pan.2015.02.011","article-title":"The epithelial to mesenchymal transition in pancreatic cancer: A systematic review","volume":"15","author":"Beuran","year":"2015","journal-title":"Pancreatology"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1101\/gad.1415606","article-title":"Genetics and biology of pancreatic ductal ad-enocarcinoma","volume":"13","author":"Hezel","year":"2006","journal-title":"Genes Dev."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1016\/j.ejca.2005.04.044","article-title":"Molecular prognostic markers in pancreatic cancer: A systematic review","volume":"41","author":"Garcea","year":"2005","journal-title":"Eur. J. Cancer"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1001\/jama.2010.1275","article-title":"Adjuvant chemotherapy with fluorouracil plus folinic acid vs. gemcitabine following pancreatic cancer resection: A randomized controlled trial","volume":"304","author":"Neoptolemos","year":"2010","journal-title":"JAMA"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Roberto, C., Alberto, C., Vincenzo, L.V., Roberto, C., and Damiano, C. (2025). Neoadjuvant Therapy in Pancreatic Ductal Adenocarcinoma: Aligning Guideline Recommendations with Real-World Evidence. Cancers, 17.","DOI":"10.3390\/cancers17183085"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1097\/00000478-200407000-00001","article-title":"Pathologically and biologically distinct types of epithelium in intraductal papillary mucinous neoplasms: Delineation of an \u201cintestinal\u201d pathway of carcinogenesis in the pancreas","volume":"28","author":"Adsay","year":"2004","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Pignochino, Y., Sarotto, I., Peraldo-Neia, C., Penachioni, J.Y., Cavalloni, G., Migliardi, G., Casorzo, L., Chiorino, G., Risio, M., and Bardelli, A. (2010). Targeting EGFR\/HER2 pathways enhances the antiproliferative effect of gemcitabine in biliary tract and gallbladder carcinomas. BMC Cancer, 10.","DOI":"10.1186\/1471-2407-10-631"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/00006676-200301000-00008","article-title":"Tumor-suppressing pathways in cystic pancreatic tumors","volume":"13","author":"Gerdes","year":"2003","journal-title":"Pancreas"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"6469","DOI":"10.1038\/sj.onc.1210477","article-title":"The oncogene HER2: Its signaling and transforming functions and its role in human cancer pathogenesis","volume":"26","author":"Moasser","year":"2007","journal-title":"Oncogene"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.phrs.2013.11.002","article-title":"The ErbB\/HER family of protein-tyrosine kinases and cancer","volume":"79","author":"Roskoski","year":"2014","journal-title":"Pharmacol. Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/PAI.0b013e31828dc392","article-title":"HER2 gene amplification and protein expression in pancreatic ductal adenocarcinomas","volume":"22","author":"Aumayr","year":"2014","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"3356","DOI":"10.1158\/1078-0432.CCR-06-2302","article-title":"In vivo Therapeutic syner-gism of anti-epidermal growth factor receptor and anti-HER2 monoclonal antibodies against pancreatic carcinomas","volume":"13","author":"Larbouret","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"3294","DOI":"10.1073\/pnas.0812059106","article-title":"Persistent elimination of ErbB-2\/HER2-overexpressing tumors using combinations of monoclonal antibodies: Relevance of receptor endocytosis","volume":"106","author":"Schechter","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nrc1609","article-title":"ERBB receptors and cancer: The complexity of targeted inhibitors","volume":"5","author":"Hynes","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.3748\/wjg.v22.i4.1335","article-title":"Molecular genetics and targeted therapeutics in biliary tract carcinoma","volume":"22","author":"Marks","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"6550","DOI":"10.1038\/sj.onc.1204082","article-title":"The EGF receptor family as targets for cancer therapy","volume":"19","author":"Mendelsohn","year":"2000","journal-title":"Oncogene"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Barzi, A., Weipert, C.M., Espenschied, C.R., Raymond, V.M., Wang-Gillam, A., Nezami, M.A., Gordon, E.J., Mahadevan, D., and Modym, K. (2024). ERBB2 (HER2) amplifications and co-occurring KRAS alterations in the circulating cell-free DNA of pancreatic ductal adenocarcinoma patients and response to HER2 inhibition. Front. Oncol., 14.","DOI":"10.3389\/fonc.2024.1339302"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Kankana, B., Avik, S., Rahul, K., and Aryya, G. (2025). Identification of key hub genes in pancreatic ductal adenocarcinoma: An integrative bioinformatics study. Front. Bioinform., 5.","DOI":"10.3389\/fbinf.2025.1536783"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/s41571-025-01008-y","article-title":"Emerging importance of HER3 in tumorigenesis and cancer therapy","volume":"22","author":"Joan","year":"2025","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1002\/j.1460-2075.1996.tb00603.x","article-title":"Diversification of Neu differentiation factor and epidermal growth factor signaling by combinatorial receptor interactions","volume":"15","author":"Soussan","year":"1996","journal-title":"EMBO J."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"21608","DOI":"10.1073\/pnas.0912101106","article-title":"Structural analysis of the catalytically inactive kinase domain of the human HER3 receptor","volume":"106","author":"Jura","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_26","first-page":"3550","article-title":"ErbB3 is involved in activation of phosphatidylinositol 3-kinase by epidermal growth factor","volume":"14","author":"Soltoff","year":"1994","journal-title":"Mol. Cell Biol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"5878","DOI":"10.1158\/0008-5472.CAN-08-0380","article-title":"A central role for HER3 in HER2-amplified breast cancer: Implications for targeted therapy","volume":"68","author":"Crocker","year":"2008","journal-title":"Cancer Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1038\/bjc.1998.689","article-title":"Expression of c-erbB3 protein in primary breast carcinomas","volume":"78","author":"Naidu","year":"1998","journal-title":"Br. J. Cancer"},{"key":"ref_29","first-page":"e930545","article-title":"Prognostic Significance of Microvascular Invasion in Pancreatic Ductal Adenocarcinoma: A Systematic Review and Meta-Analysis","volume":"27","author":"Huangbao","year":"2021","journal-title":"Med. Sci. Monit."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"4258","DOI":"10.1007\/s12325-021-01819-2","article-title":"Lymph Node Metastatic Patterns and Survival Predictors Based on Tumor Size in Pancreatic Ductal Adenocarcinoma","volume":"38","author":"Ning","year":"2021","journal-title":"Adv. Ther."},{"key":"ref_31","first-page":"283","article-title":"HER2\/neu expression and gene alterations in pancreatic ductal adenocarcinoma: A comparative immunohistochemistry and chromogenic in situ hybridization study based on tissue microarrays and computerized image analysis","volume":"7","author":"Tsiambas","year":"2006","journal-title":"JOP"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"6652","DOI":"10.1158\/0008-5472.CAN-04-1168","article-title":"A unique structure for epidermal growth factor receptor bound to GW572016 (Lapatinib): Relationships among protein conformation, inhibitor off-rate, and receptor activity in tumor cells","volume":"64","author":"Wood","year":"2004","journal-title":"Cancer Res."},{"key":"ref_33","first-page":"284","article-title":"The Site of Lymph Node Metastasis: A Significant Prognostic Factor in Pancreatic Ductal Adenocarcinoma","volume":"38","author":"Aysal","year":"2022","journal-title":"Turk. J. Pathol."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Takahashi, H., Katsuta, E., Yan, L., Katz, M.H.G., and Takabe, K. (2020). Transcriptomic Profile of Lymphovascular Invasion, a Known Risk Factor of Pancreatic Ductal Adenocarcinoma Metastasis. Cancers, 12.","DOI":"10.3390\/cancers12082033"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1159\/000333825","article-title":"HER3 Overexpression as an Independent Indicator of Poor Prognosis for Patients with Curatively Resected Pancreatic Cancer","volume":"81","author":"Hirakawa","year":"2011","journal-title":"Oncology"},{"key":"ref_36","first-page":"S3","article-title":"Current treatment landscape and emerging therapies for pancreatic cancer","volume":"25","author":"Adel","year":"2019","journal-title":"Am. J. Manag. Care."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"zrad125","DOI":"10.1093\/bjsopen\/zrad125","article-title":"Lymph node examination and survival in resected pancreatic ductal adenocarcinoma: Retrospective study","volume":"8","author":"Ruediger","year":"2024","journal-title":"BJS Open."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","article-title":"Projecting cancer incidence and deaths to 2030: The unexpected burden of thyroid, liver, and pancreas cancers in the United States","volume":"74","author":"Rahib","year":"2014","journal-title":"Cancer Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/00006676-200407000-00061","article-title":"The correlation between cytoplasmic overexpression of epidermal growth factor receptor and tumor aggressiveness: Poor prognosis in patients with pancreatic ductal adenocarcinoma","volume":"29","author":"Ueda","year":"2004","journal-title":"Pancreas"}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/2\/251\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T10:59:16Z","timestamp":1769425156000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/2\/251"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,24]]},"references-count":39,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["medicina62020251"],"URL":"https:\/\/doi.org\/10.3390\/medicina62020251","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,24]]}}}